Bio-Optronics Introduces CTMS Upgrade
Bio-Optronics Inc. has announced the release of an upgrade for Clinical Conductor CTMS, which now includes patient management for care quality.
Bio-Optronics Inc. has announced the release of an upgrade for Clinical Conductor CTMS, which now includes patient management for care quality. This updated solution offers users access to multiple checklists, including patient and visit checklists, providing accountability for successfully complete patient visits.
Read the full release here
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
